In vivo Analgesics and in vitro Antioxidants Activity of Newly Synthesized Mannich Bases of Lawsone

 

Gulam Muheyuddeen1*, Sarwar Husain Rayini2, Priyanka Yadav3, Sujeet Kumar Gupta4

1Research Scholar, Hygia Institute of Pharmaceutical Education and Research, Lucknow, Uttar Pradesh.

2Assistant Professor, Maharana Pratap College of Pharmacy, Kanpur, Uttar Pradesh

3Assistant Professor, Hygia Institute of Pharmaceutical Education and Research, Lucknow, Uttar Pradesh.

4Professor and Head, Pharmaceutical Chemistry, Hygia Institute of Pharmaceutical Education and Research, Lucknow, Uttar Pradesh.

*Corresponding Author E-mail: gulammuheyuddeen7860@gmail.com

 

ABSTRACT:

1, 4- naphthoquinone (Lawsone) is widely distributed in nature and has been used since ancient times in traditional medicine. Lawsone has been used as a dye, and both its natural form and synthetic derivatives exhibit antifungal, antibacterial, antitumor, Antimalarial, molluscicidal, and antioxidant activity. 1, 4- naphthoquinone (Lawsone) was isolated from the leaves of Lawsonia inermis by using the pH gradient (agitation) and maceration method. A convenient synthesis of 2-substituted amino naphthalene-1, 4-dione (3a-o) has been achieved by reaction of isolated 1, 4- naphthoquinone with substituted aniline in the presence of ethanol and DPPH model is used for the evaluation of the antioxidant activities and in vivo analgesic activity using albino mice morphine-induced hot plate method. The structure of the ultimate analogs has been inveterate on the basis of elemental analysis, IR, 1H NMR, and mass spectra. All the standards of elemental investigation, IR, 1H NMR, and mass spectra were initiate to be prominent. The results indicate that synthesized compound 3d having IC50 75.39 ± 4.12mg/ml showed potent antioxidant activity comparable to standard ascorbic acid (IC50 45.54 ± 3.06mg/ml). 3c, 3m, and 3o showed potent analgesic activity comparable to standard nimesulide (100% at 50mg/kg b.w). This reading suggests that leaves of Lawsonia inermis have bioactive compounds for innovative antioxidant and analgesic remedy development.

 

KEYWORDS: Lawsonia inermis, heterocyclic compounds, substituted aniline, Naphthoquinone, In-vitro antioxidant activity, In vivo analgesic activity, leaves extract, DPPH, Eddy hot plate.

 


 

INTRODUCTION:

Naphthoquinone derivatives have pulled in proceeding with enthusiasm throughout the years due to the utilization of its ring framework as a vital center constitution in numerous medicine substances and are reported to cover up a broad variety of pharmacological implementation1-2.

 

Due to their varied pharmacological qualities, such as their antioxidant activity, plant-derived natural products such as Phenolic compounds (flavonoids), steroids, terpinoids, saponins, volatile oils, glycosides, etc. have drawn a lot of attention in recent years.

 

Furthermore, 1, 4 naphthoquinones in particular are abundantly dispersed. Naphthoquinones are Phenolic compounds that are believed to have a variety of pharmacological activities, including antibacterial, antifungal, antiviral, anti-inflammatory, antipyretic, and anticancer action.4,24. Humans are protected against infection and degenerative diseases by antioxidants, which are crucial in blocking and scavenging free radicals5. Although experiments and clinical trials involving entire animals are imperative in plant product assaying however the significance of in vitro assaying is picking up prevalence because of money-related, moral, and time requirements. The aptitude to quickly recognize active compounds in the intricate assortment of plant product extract, lead optimization as well as lead characterization are significant factors in plant product assaying. Natural plant-based antioxidants have been extensively studied, and their value in food, health, and preventative medicine is well known6-10. The current study reports on a comparison of the in-vitro antioxidant activity of various naphthoquinone derivatives, which may aid in the discovery of new antioxidant compounds (s).  Because of the above mention and as a part of our continuous efforts towards the development of more potent antioxidant and analgesic agents 11. It was thought of interest to combine the above-mentioned boilable rings in a molecular framework to investigate the additive effect of these rings on antioxidant and analgesic activities.

 

1.     Chemistry:

Naphthoquinone (1) (300mg, 1.89mmol) in 20 mL absolute ethanol was stirred at 5-10ºC until the solid completely dissolved. To this naphthoquinone, the solution was added drop wise a solution of the corresponding amine (2) (0.95mmol) in 10mL of absolute ethanol at 5-10ºC.

 

The reaction mixture was allowed to reach room temperature and was stirred for another 12–18h. The completion of the reaction was monitored by TLC. The solid product thus obtained was filtered, washed with water, and Recrystallize from acetone to give compounds (3a-o)12-13.

 

Elemental analysis, yield, and melting points were given in Table 1. This protocol is very significant because of its specific generation of crystalline products. The synthesized compounds were characterized by IR, 1H NMR, ESI-MS, and elemental analysis.

 

2.     Pharmacological evaluation:

All the compounds prepared here were assayed for their pharmacological actions for instance in-vivo palliative and in vitro antioxidant behavior. The physiological reactions of animals to heat and chemical stimuli were measured during these activities. For palliative activity in mice20-21 at 50mg/kg body weight (b.w) have performed. The % of fortification has deliberate compared to standard drug nimesulide. The entire compounds showed persuasive activity compared with Nimesulide. For antioxidants activity, the DPPH method is used. The % of fortification has calculated compared to standard drug ascorbic acid. The entire compounds showed persuasive activity compared with ascorbic acid.

 

3. RESULTS AND DISCUSSION:

3.1. Chemistry:

1, 4- naphthoquinone derivatives with various substituted aromatic amines by stirring in ethanol for 12-18 h yielded substituted (substituted aniline) naphthalene-1, 4-dione derivatives (a-o) according to the literature method22. The maintenance of minimum temperature (5ºC) is very important as it led to crystalline products. The corresponding yields (57–89%) were obtained in good agreement. The postulated structures of newly synthesized targeted naphthalene-1,4-dione derivatives are under the elemental analysis, IR, 1H NMR, and ESI-MS. IR spectra of all the compounds showed stretching bands at 3402–3590 cm-1 of aromatic –NH respectively. Further (C-N) stretching bands appeared at 1552–1585 cm-1 respectively. The 1H NMR spectral broad singlet signals were observed at d 2.12–5.2 NH protons of aliphatic and NH protons of naphthalene-1,4-dione are merged with aromatic and are D2O exchangeable. ESI-MS spectra showed the corresponding molecular ion peaks for all the compounds. All the spectral results of 2-(substituted aniline) naphthalene-1,4-dione derivatives (a-o) are tabulated in Table 2.

 

 

SCHEME

 

Fig. 1: Synthetic protocol of compound (3a -0)

 

Fig. 2: Reaction of DPPH Model

 

 

3.2. Analgesic activity:

The analgesic activity of the synthesized compounds was assessed by the morphine-induced hot plate method. Almost all the compounds have shown very potent analgesic activity when compared with standard nimesulide drugs. Among the tested compounds 2-(4-hydroxyphenylamino) naphthalene-1, 4-dione (3c), 2-((2,4-dinitrophenyl) amino) naphthalene-1,4-dione (3m), 2-((2-fluorophenyl) amino) naphthalene-1,4-dione (3o) showed pronounced analgesic activity (89%, 100mg/kg b.w). The remaining compounds 3a, 3b, 3d, 3e, 3f, 3g, 3h, 3i, 3j, 3k, 3l, and 3n have also shown good activity because methoxy, hydroxy, methyl, nitro, methylthio, phenoxy, and ethoxy substituted anilines. Within the same ring system i.e., substituted anilines, it was noticed that the introduction of 2, 4-dihydroxy, and methyl groups in the naphthoquinone ring and nitro group in the aniline at different positions enhanced the analgesic activity. Several studies suggested the analgesic effect of the derivative and formulating with several nanogels to obtain maximum activity.23

 

 

3.3 Antioxidants activity:

DPPH assay was discovered by Goldschmidt and Renn in the 1920s. It is a stable free radical with purple color which turns yellow when scavenged. DPPH is used for measuring the total antioxidant capacity (TAC). Antioxidant capacity is the overall ability of organisms or food to catch free radicals and prevents their harmful effects.

DPPH (1, 1-diphenyl-2-picrylhydrazyl) technique is the most excellent, straightforward, and most frequently used technique for evaluating prelude free radical-scavenging activity 14-15. In chemical analysis, the stable free radical DPPH is typically used to identify the action of radical scavengers. It has an unusual electron in its structure. Labile hydrogen is known to be abstracted by DPPH. 16-17 the reaction is summerised in fig.2.

 

3.4 CONCLUSION:

In conclusion, we have described a simple and efficient protocol for the preparation of 2-(2-substituted aryl amino) naphthalene-1, 4-dione derivatives with excellent yields. All the synthesized compounds have been screened for their in-vivo analgesics and vitro antioxidant activities. In newly synthesized compounds, it is clear that the highest analgesic activity in compounds 3c, 3m, 3o, and antioxidants activity in compound 3d was observed. Apart from compounds 3c, 3m, and 3o, the remaining compounds have shown good analgesic activity almost equal to standard nimesulide drugs. compounds 3a,3b,3d,3e,3f,3g,3h,3i,3j,3k,3l and 3n have shown moderate antioxidant activity .the preliminary in vivo studies for analgesics as well as in vitro studies for antioxidants the compounds evidenced that the chloro group, methoxy, phenyl as well as the nitro group in the meta position in the aniline ring enhance the analgesics as well as antioxidants activities, They could work as fresh models in the creation of strong treatments; as a result, it can be said that these substances exhibit pharmacological activity. This has had a positive effect on chemists and biochemists who are now looking into drug design further in order to find analgesics and antioxidants with halo, nitro, methyl, and phenyl functional groups.

 

Table -1 Physical data for synthesized compounds and isolated yield

Compounds

Molecular formula

Yield (%)

MP(°C)

C (%)

N (%)

H (%)

O%

Cacld

Found

Cacld

Found

Cacld

Found

Cacld

Found

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

C17H13NO3

C17H13NO3

C16H11NO3

C16H11NO4

C17H13NO2

C18H15NO2

C18H15NO3

C16H11NO3

C16H10N2O4

C17H13NO2S

C17H10N2O2

C18H13NO3

C16H9N3O6

C22H15NO3

C16H10FNO2

57%

68%

66%

73%

87%

73%

82%

74%

69%

63%

67%

68%

76%

69%

67%

196 ºC

190 ºC

192 ºC

263 ºC

227 ºC

202 ºC

210 ºC

198 ºC

210 ºC

220 ºC

224 ºC

218 ºC

224 ºC

228 ºC

194 ºC

73.15

73.15

72.51

68.49

77.61

78.02

73.76

72.51

65.36

69.17

74.52

74.32

74.73

77.46

71.97

73.11

73.11

72.45

68.33

77.55

77.96

73.71

72.45

65.31

69.13

74.44

74.22

56.65

77.41

71.91

5.07

5.07

5.34

5.08

5.41

5.08

4.83

5.34

9.57

4.79

10.33

4.89

12.46

4.16

5.32

5.02

5.02

5.28

4.98

5.32

5.05

4.78

5.28

9.52

4.74

10.21

4.81

12.39

4.10

5.24

4.76

4.76

4.23

3.98

5.07

5.56

5.22

4.26

3.49

4.56

3.73

4.56

2.75

4.49

3.84

4.69

4.69

4.18

3.94

4.98

5.49

5.15

4.18

3.43

4.44

3.68

4.50

2.67

4.43

3.77

17.23

17.23

18.16

22.84

12.22

11.67

16.45

18.19

21.83

10.89

11.76

16.57

28.38

14.17

12.09

17.19

17.19

18.09

22.75

12.15

11.54

16.36

18.09

21.75

10.83

11.67

16.48

28.29

14.06

11.97


 

 

4. EXPERIMENTAL PROTOCOLS:

4.1 Collection of Plant Material:

The whole plants of Lawsonia inermis were collected from several habitats in the Amethi and Shravasti district region of Uttar Pradesh, India. Lawsonia inermis wasidentified and authenticated by Dr. Sunita Garg former chief scientist, and head, at RHMD, CSIR-NIScPR. A voucher specimen no (NIScPR/RHMD/ Consult/2021/3982-83) was deposited in the raw material herbarium and museum, Delhi (MHRD). And the leaves were washed in running water and air-dried.

 

4.2 Chemicals:

These were the purchases. Organic solvents: petroleum ether, DMSO, and diethyl ether, from Central Drug House (P) Ltd.; acetone, chloroform, n-hexane, ethyl acetate, and ethanol from Qualigens® Fine Chemicals (Mumbai) (New Delhi), and ethanol from Changshu Hongsheng fine chemical co., ltd. Changshu city, Jiangsu Province. (all analytical grades). 1,1-Diphenyl-2-picrylhydrazyl radical from Sigma-Aldrich (New Delhi). Other reagents used were of analytical grade and obtained from different commercial sources.

 

4.3 Material and method:

The melting points of the products were determined by open capillaries on a Thiele tube Fisher john’s apparatus and are found to be 196 °C. The IR spectra were recorded on a Shimadzu FTIR-8400s Spectrophotometer, using KBr pellets. 1H NMR spectra were recorded on a Bruker Avance 400/AvIII HD300 (FT NMR) spectrometer in CDCl3 using TMS as an internal standard with a 1H resonant frequency of 300 MHz. The Mass spectra were recorded on a Waters Alliance e2695/HPLCTQD Mass spectrometer (ESI-MSThe EuroVector analyzer was used to do the elemental analysis. All of the compounds produced C, H, O, and N analyses that were within 5% of the predicted values. TLC was used to describe the homogeneity of the compounds on aluminium silica gel 60 F254 (Merck), which was detected by UV light (254 nm) and iodine vapors. All reagents were analytical graded or chemically pure.

 

4.4 Isolation and Purification of Lawson:

Shade dried and 200 g powered henna are extracted by agitation for 2 h with 20% sodium bicarbonate solution (800 ml). The extract was filtered, marc is re-extracted with 400 ml of the same solution for 1hr, filtered and the alkaline extract was pooled together. The extract was acidified with dil. sulphuric acid and crude product obtained on standing was re-extracted with a sufficient quantity of ammonium hydroxide and again acidified with dil. hydrochloric acid. The product is finally extracted with two successive quantities of benzene (160 ml) and filtered 12. The filtrate was distilled to yield a yellow-brown color crystal of lawsone and the purity was checked by TLC. The red spot obtained had an Rf value of 0.07 and its melting point was obtained as 196oC.

 

4.5 General procedure for the synthesis of 2-(2-substituted) naphthalene-1, 4-Dione (3a-o): Naphthoquinone (1) (300 mg, 1.89 mmol) in 20 mL absolute ethanol has stirred at 5-10 ºC in anticipation of the solid completely solvated. To this naphthoquinone, Dropwise, a solution of the appropriate amine (2) (0.95 mmol) has been added to the reaction mixture in 10 mL of absolute ethanol at 5-10 ºC. The homogenate was brought to room temperature and agitated for a further 12 to 18 hours. The completion of the reaction was monitored by TLC. The solid product thus obtained was filtered, washed with water, and recrystallized from acetone to give compounds (3a-o) 13.


 

Table 2: Spectral analysis of synthesized compound Analgesic activity of tested compounds (100 mg/kg b.w) and Nimesulide (50 mg/kg b.w)

SI No

Compound and structure

Infrared cm-1 (KBr pallets)

1 H Nuclear Magnetic Resonance Values in ppm

Mass At m/z      (M+H)+

3a

 

3100 (Ar C-H), 1685, 1676 (C=O, a,β unsaturated ), 1285 (C-N), 3403 (N-H), 1570 (C=C), 1204 (C-O-C asym.), 1033 (C-O-C sym)

3.74 (s, 3H, OCH3 ),

4.17 (s, 1H, H-N, D2O exchangeable),

 6.31-7.02 (m, 4H, Ar-H),

7.92-8.15 (d, 2H, Ar-H), 8.19-8.22 (dd, 2H, Ar-H),

8.43 (s, 1H, Ar-H )

279.8954

 

3b

 

3055 (Ar C-H), 1655, 1678 (C=O, a,β unsaturated), 1277 (C-N), 3409 (N-H), 1590 (C=C), 1230 (C-O-C asym.), 1028 (C-O-C sym)

 

3.72 (s, 3H, OCH3 ),

4.05 (s, 1H, NH, D2O exchangeable),

 6.88-6.92 (m, 4H, ArH), 7.66-7.90 (d, 2H, Ar-H), 8.06-8.11 (dd, 2H, Ar-H), 8.23 (s, 1H, ArH)

 

279.8954

 

3c

 

3107 (Ar C-H), 1645, 1654 (C=O, α, β unsaturated), 1256 (C-N), 3402 (N-H), 1509 (C=C), 1102 (C-O), 3599 (O-H)

 

4.73 (s, 1H, NH, D2O exchangeable),

 5.02 (s, 1H, OH, D2O exchangeable),

6.02-6.95 (m, 4H, Ar-H), 7.12-7.89 (d, 2H, Ar-H), 7.99-8.43 (dd, 2H, Ar-H)

 

265.7389

 

3d

 

3102 (Ar C-H), 1633, 1687 (C=O, a,β unsaturated),), 1282 (C-N), 3412 (N-H), 1554 (C=C), 1209 (C-O), 3599 (O-H)

4.36 (s, 1H, NH, D2O exchangeable),

5.02 (s, 2H, OH, D2O exchangeable),

 6.85- 6.97 (m, 6H, Ar-H), 7.88-7.92 (d, 2H, Ar-H)

281.6881

 

3e

 

3035 (Ar C-H), 1635, 1640 (C=O, a,β unsaturated), 1272 (C-N), 3490 (N-H), 1535 (C=C), 1289 (C-O), 3578 (O-H)

 

2.32 (s, 3H, CH3 ),

4.28 (s, 1H, NH, D2O exchangeable),

6.22-6.91 (m, 4H, Ar-H), 7.19-7.27 (d, 2H, Ar-H), 7.60-7.74 (dd, 2H, Ar-H), 7.96 (s, 1H, Ar-H)

263.9463

 

3f

 

3135 (Ar C-H), 16355, 1660 (C=O, a,β unsaturated), 1292 (C-N), 3570 (N-H), 1635 (C=C)

2.22 (s, 3H, CH3 ),

4.18 (s, 1H, NH, D2O exchangeable),

6.27-7.21 (m, 4H, Ar-H), 7.49-7.87 (d, 2H, Ar-H), 7.50-7.64 (dd, 2H, Ar-H), 7.76 (s, 1H, Ar-H)

277.1102

 

3g

 

3070 (Ar C-H), 1645, 1650 (C=O, a,β unsaturated), 1278 (C-N), 3495 (N-H), 1545 (C=C), 1299 (C-O), 3576 (O-H)

2.33 (s, 3H, CH3 ),

4.29 (s, 1H, NH, D2O exchangeable),

6.23-6.92 (m, 4H, Ar-H), 7.29-7.37 (d, 2H, Ar-H), 7.65-7.79 (dd, 2H, Ar-H), 7.86 (s, 1H, Ar-H)

293.1051

 

3h

 

3028 (Ar C-H), 1632, 1637 (C=O, a,β unsaturated), 1253 (C-N), 3498 (N-H), 1525 (C=C), 3593 (O-H)

2.33 (s, 3H, CH3 ),

4.38 (s, 1H, NH, D2O exchangeable),

6.16-6.85 (m, 4H, Ar-H), 7.16-7.27 (d, 2H, Ar-H), 7.60-7.69 (dd, 2H, Ar-H), 7.94 (s, 1H, Ar-H)

265.7389

 

3i

 

3025 (Ar C-H), 1615, 1620 (C=O, a,β unsaturated), 1252 (C-N), 3490 (N-H), 1525 (C=C)

2.12 (s, 3H, CH3 ),

4.18 (s, 1H, NH, D2O exchangeable),

6.13-6.90 (m, 4H, Ar-H), 7.17-7.25 (d, 2H, Ar-H), 7.50-7.64 (dd, 2H, Ar-H), 7.94 (s, 1H, Ar-H)

294.6406

 

3j

 

3035 (Ar C-H), 1635, 1720 (C=O, a,β unsaturated), 1272 (C-N), 3590 (N-H), 1635 (C=C)

 

2.34 (s, 3H, CH3 ),

4.26 (s, 1H, NH, D2O exchangeable),

6.18-6.88 (m, 4H, Ar-H), 7.29-7.37 (d, 2H, Ar-H), 7.50-7.64 (dd, 2H, Ar-H), 7.66 (s, 1H, Ar-H)

 

295.6670

 

3k

 

3095 (Ar C-H), 1735, 1740 (C=O, a,β unsaturated), 1282 (C-N), 3520 (N-H), 1645 (C=C)

 

2.34 (s, 3H, CH3 ),

4.32 (s, 1H, NH, D2 O exchangeable),

6.13-6.83 (m, 4H, Ar-H), 7.15-7.23 (d, 2H, Ar-H), 7.58-7.72 (dd, 2H, Ar-H), 7.98 (s, 1H, Ar-H)

274.7423

 

3l

 

3095 (Ar C-H), 1735, 1740 (C=O, a,β unsaturated), 1282 (C-N), 3520 (N-H), 1645 (C=C)

 

2.36 (s, 3H, CH3 ),

4.31 (s, 1H, NH, D2O exchangeable),

6.25-6.94 (m, 4H, Ar-H), 7.21-7.29 (d, 2H, Ar-H), 7.62-7.76 (dd, 2H, Ar-H), 7.94 (s, 1H, Ar-H)

291.8954

 

3m

 

3015 (Ar C-H), 1625, 1630 (C=O, a,β unsaturated), 1267 (C-N), 3477 (N-H), 1655 (C=C), 1589 (N-O)

 

2.42 (s, 3H, CH3), 4.38 (s, 1H, NH, D2O exchangeable), 6.32-6.81 (m, 4H, Ar-H), 7.14-7.32 (d, 2H, Ar-H), 7.64-7.78 (dd, 2H, Ar-H), 7.93 (s, 1H, Ar-H)

 

339.4914

 

3n

 

3085 (Ar C-H), 1715, 1720 (C=O, a,β unsaturated), 1252 (C-N), 3480 (N-H), 1654 (C=C), 1279 (C-O)

 

2.32 (s, 3H, CH3),

4.29 (s, 1H, NH, D2O exchangeable),

6.23-6.93 (m, 4H, Ar-H), 7.21-7.29 (d, 2H, Ar-H), 7.58-7.71 (dd, 2H, Ar-H), 7.89 (s, 1H, Ar-H)

 

341.1051

 

3o

 

3135 (Ar C-H), 1605, 1610 (C=O, a,β unsaturated), 1282 (C-N), 3530 (N-H), 1635 (C=C)

2.31 (s, 3H, CH3 ),

4.27 (s, 1H, NH, D2O exchangeable),

6.27-6.83 (m, 4H, Ar-H), 7.17-7.22 (d, 2H, Ar-H), 7.54-7.71 (dd, 2H, Ar-H), 7.96 (s, 1H, Ar-H)

267.6956

 


Table 3 Data represent mean values ± SE of six mice per group, shown at the final value for each group (saline, nimesulide, and tested compounds) after 3 h.

Compound

Mean writhing (X±SE)

Protection (%)

Control

30.05±1.57

-

1

8.5±3.35

72.35

2

5.7±1.87

81.35

3

8.6±1.48

70.33

4

5.0±2.53

83.38

5

6.0±2.00

80.00

6

6.0±0.59

80.22

7

3.3±1.69

89.00

8

4.3±2.02

85.77

9

5.07±2.09

83.34

10

3.6±2.39

88.46

11

6.3±1.49

79.00

Nimesulide

-

100.00

Data were analyzed using one-way ANOVA followed by Turkey–Krammer Multiple comparison test **p < 0.01.

Percentage change was calculated from basal (pre-drug) values.

 

And post-drug values. Protection was calculated as regards the percentage change of the Nimesulide. SE, standard error; Nim. Nimesulide.

 

The active compounds are marked in bold letters.

Table 4 data for antioxidant analysis

Calculation of % Radical Scavenging and IC50 from DPPH assay

Absorbance measurement data

Concentration (µg/ml)

Control

Sample

%RSA

IC50

50

0.52

0.312

40

2.34

100

0.52

0.291

44.03846

7.73

150

0.52

0.228

56.15385

13.12

200

0.52

0.18

65.38462

18.51

250

0.52

0.14

73.07692

23.90

300

0.52

0.075

85.57692

29.29

350

0.52

0.035

93.26923

34.68

 

4.6. Animals used:

For the purpose of researching acute toxicity, adult Swiss albino mice (20-25g) and albino rats (150-200g) of either sex were employed. In each group, six animals were housed individually in polypropylene cages with paddy husk beds. Animals were maintained at 25–27 C and 30–70% relative humidity. The study protocol was approved by the Institutional Animal Ethics Committee (IACE, Reg. No. 346/CPCSEA: Dated. 21-09-2022) before the experiment.

 

4.7. Analgesic activity screening:

The morphine-induced writhing model was used to assess the palliative action of the synthesized compounds. Five groups of six Swiss albino mice, each 20–25g b.w, were used. 0.6% morphine (dose ¼ 10 ml/Kg) was injected intra-peritoneally. The numbers of writhes were counted for 20 min, after 5 min of injection of morphine into each mouse. This reading was taken as a control. The next day, the same groups of mice were used for evaluating analgesic activity. Each group was administered orally with the synthesized compounds. The dose of 100 mg/kg of animal was given 1 hour before injection of morphine. After 5 min of morphine injection, mice were observed for the number of writhings for 20 min. The mean value for each group was calculated and compared with the control. Nimesulide was used as a standard drug for comparison of analgesic activity. Percent protection was calculated using the following formula:

 

(1-Vc/Vt)*100

 

Where

Vt = Mean number of writhing in test animals and

Vc = Mean number of writhing in control. Statistical significance was analyzed using one-way ANOVA followed by Turkey–Krammer Multiple comparison tests and p < 0.01 was considered significant.

 

4.8. Antioxidant activity screening:

DPPH-radical scavenging activity of synthesized compounds (3a-o) was measured in terms of hydrogen donating or radical scavenging ability using the stable radical DPPH. Solution of DPPH was prepared and was added to all the synthesized compounds (3a-o) at different concentrations (1-1000mg/ml). Thirty minutes later, the absorbance was measured at 517 nm. Among the tested compound (3d) 2-(2, 4-dihydoxyphenylamino) naphthalene-1, 4-dione showed pronounced antioxidant activity. All the analysis was made with the use of a UV-Visible Spectrophotometer (Shimadzu 1700). The absorbance of various concentrations was taken and percentage inhibition was calculated. Lower absorbance of the reaction mixture indicates higher free radical-scavenging activity. Ascorbic acid was used as a standard antioxidant. IC50 (Inhibitory Concentration 50%) value denotes the concentration of sample required to scavenge 50% of the DPPH free radical. IC50 of all synthesized compounds (3a-o) was determined from the % Inhibition v/s concentration graph (Figure 1). The percentage discoloration was calculated as follows:

 

DPPH radical scavenging activity (%) =

[AC517 – AE517 / AC517] x 100.

 

Where;

AC517 is the absorbance of a DPPH solution without fraction,

AE517 is the absorbance of the tested compounds with DPPH.

 

Figure 3 The graph shows that high activity in ascorbic acid (Std) then isolated compound

 

4.9 Statistical analysis:

In the analgesic and antioxidant study, the results of the experiment were expressed as mean±SEM. For group comparison, analysis of variance followed by Tukey’s HSD multiple comparison test with SPSS version 10 was used. The difference among means was considered statistically significant when the p-value was less than 0.05.

 

5. ACKNOWLEDGMENTS:

The authors would like to thank the management of Hygia Institute of Pharmaceutical Education and, Lucknow for providing research facilities. CDRI, Lucknow As well As GLA University Mathura is acknowledged for providing the spectral data of the synthesized compounds.

 

6. REFERENCES:

1.      O’Brien, P. J. Chem.-Biol. Interact. 1991, 80, 1-41.

2.      Monks, T.J.; Hanzlik, R.P,: Cohen, G.M,: Ross, D,: Graham, D.G,; Toxicol. Appl. Pharmacol, 1992, 112, 2-16.

3.      Babula P, Adam V, Havel L, Kizek R. Naphthoquinones and their pharmacological properties. Ceská a Slovenská Farmacie, 2007, 56, 114-120.

4.      Kim BH, Yoo J, Park SH, Jung JK, Cho H. Synthesis and evaluation of antitumor activity of novel 1,4- naphthoquinone derivatives (IV). Archives of Pharmacal Research, 2006, 29, 123-130.

5.      Smith MT, Evans CG, Thor H, Sten O. Quinones-induced oxidative injury to cells and tissues. In: Helmet, S. (Ed.), Oxidative stress. Academic Press Inc., London, 1985 1–91.

6.      El Bialya SAA, Gouda MA. Cyanoacetamide in heterocyclic chemistry: Synthesis, antitumor and antioxidant activities of some new benzothiophenes. Journal of Heterocyclic Chemistry, 2011, 48, 1280–1286.

7.      Hamama WS, Berghot MA, Baz EA, Gouda MA. Synthesis and antioxidant evaluation of some new 3-substituted coumarins. Archiv der Pharmazie, 2011, 344, 710-718.

8.      Hamama WS, Zoorob HH, Gouda MA, Afsah EM. Synthesis and antimicrobial and antioxidant activities of simple Saacharin derivatives with N-basic side chains. Pharmaceutical Chemistry Journal, 2011, 45, 118-124.

9.      Gouda MA, Abu-Hashem AA. Synthesis, characterization, antioxidant and antitumor evaluation of some new thiazolidine and thiazolidinones derivatives. Archiv der Pharmazie, 2011, 344, 170-177.

10.   Gouda MA, Berghot MA, Baz EA, Hamama WS. Synthesis,antitumor and antioxidant evaluation of some new thiazole and thiophene derivatives incorporated coumarin moiety. Medicinal Chemistry Research, 2011, 21, 1062-1070.

11.   Yogi B, Murti Y, Pathak D. In-vitroantioxidant activity of column chromatography elutes of different extracts of Calotropis procera (giant milkweed) leaves. Journal of Pharmacy Research, 2011, 4(10), 1-3.

12.   Kokate, CK.  Practical Pharmacognosy. Vallabh Prakashan, Delhi, 1994, 146–47.

13.   Sieveking I, Thomas P, Estévez JC, Quiñones N, Cuéllar MA, Villena J, Espinosa-Bustos C, Fierro A, Tapia RA, Maya JD, López-Muñoz R. 2-Phenylaminonaphthoquinones and related compounds: Synthesis, trypanocidal and cytotoxic activities. Bioorganic and medicinal chemistry. 2014 Sep 1;22(17):4609-20.

14.   Koleva II, Van Beek TA, Linssen JP, Groot AD, Evstatieva LN. Screening of plant extracts for antioxidant activity: a comparative study on three testing methods. Phytochemical Analysis: An International Journal of Plant Chemical and Biochemical Techniques. 2002 Jan;13(1):8-17.

15.   Uddin SN, Ali ME, Yesmin MN. Antioxidant and antibacterial activities of Senna tora Roxb. American Journal of Plant Physiology. 2010 Mar;5(2):117-21.

16.   Constantin M, Bromont C, Fickat R, Massingham R. Studies on the activity of bepridil as a scavenger of free radicals. Biochemical pharmacology. 1990 Oct 1;40(7):1615-22.

17.   Matsubara N, Fuchimoto S, Iwagaki H, Nonaka Y, Kimura T, Kashino H, Edamatsu R, Hiramatsu M, Orita K. The possible involvement of free radical scavenging properties in the actions of cytokines. Research communications in chemical pathology and pharmacology. 1991 Feb 1;71(2):239-42.

18.   Yogi B, Mishra A. Synthesis, characterization and antioxidant evaluation of 2-(2-substituted) naphthalene-1,4-dione derivatives. Journal of Pharmacy Research 2016,10(10),655-659.

19.   Achar KC, Hosamani KM, Seetharamareddy HR. In-vivo analgesic and anti-inflammatory activities of newly synthesized benzimidazole derivatives. European journal of medicinal chemistry. 2010 May 1;45(5):2048-54.

20.   R. Koster, M. Anderson, E.J. De Beer, Fed. Proc. 18 (1952) 412–421.

21.   H.D.J. Collier, L.C. Dinnin, C.A. Johnson, C. Schneider, Br. J. Pharmacol. 32 (1968) 295–310.

22.   H.M.F. Madkor, A.A. Farag, S. Sh Ramses, N.A.A. Ibrahiem, J. Phosphorus Sulfur Silicon 181 (2006) 255–265

 

 

 

 

 

 

 

 

 

 

 

 

 

Received on 17.08.2022         Modified on 08.10.2022

Accepted on 14.11.2022   ©Asian Pharma Press All Right Reserved

Asian J. Pharm. Res. 2023; 13(1):11-17.

DOI: 10.52711/2231-5691.2023.00002